Evidence map›Paper›PMID 36425211›Full record

ArticleRSC advances2022

Facile synthesis of Cu N-lauroyl sarcosinate nanozymes with laccase-mimicking activity and identification of toxicity effects for

Fanwei Meng, Guofang Ma, Jiahe Qiu, Zhendong Fu, Jiaqing Yan, Lingping Wang

Open access · goldAbstract read
In one paragraph

Article in RSC advances, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 6 citations in OpenAlex.

  1. Toxics · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Fanwei MengKey Laboratory for Molecular Enzymology and Engineering, The Ministry of Education, Jilin University Changchun 130012 China wanglp@jlu.edu.cn yjq@mail.jlu.edu.cn +86-431-8515-5348.
Guofang MaKey Laboratory for Molecular Enzymology and Engineering, The Ministry of Education, Jilin University Changchun 130012 China wanglp@jlu.edu.cn yjq@mail.jlu.edu.cn +86-431-8515-5348.
Jiahe QiuKey Laboratory for Molecular Enzymology and Engineering, The Ministry of Education, Jilin University Changchun 130012 China wanglp@jlu.edu.cn yjq@mail.jlu.edu.cn +86-431-8515-5348.
Zhendong FuKey Laboratory for Molecular Enzymology and Engineering, The Ministry of Education, Jilin University Changchun 130012 China wanglp@jlu.edu.cn yjq@mail.jlu.edu.cn +86-431-8515-5348.
Jiaqing YanHospital of Stomatology, Jilin Universtiy Changchun 130012 PR China.
Lingping WangKey Laboratory for Molecular Enzymology and Engineering, The Ministry of Education, Jilin University Changchun 130012 China wanglp@jlu.edu.cn yjq@mail.jlu.edu.cn +86-431-8515-5348.ORCID https://orcid.org/0000-0003-3340-1727
Jilin University · CNStomatology Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nanozyme is a material with enzyme-like catalytic activity, which has been widely used in environmental, antibacterial, and other fields of research. However, there are few reports on the toxicity of nanozymes. In this work, nanozymes co-assembled from sodium N-lauroyl sarcosinate (Ls) and Cu ions possess a Cu(i)-Cu(ii) electron transfer system similar to that of natural laccases. Reaction kinetic studies show that the catalyst follows a typical Michaelis-Menten model. Cu-N-lauroyl sarcosinate nanozyme (Cu-Ls NZ) possess excellent laccase-like activity to oxidize a variety of phenol-containing substrates, such as phenol, 4-iodophenol, and 2,4,5-trichlorophenol. To evaluate the toxicity of the material, the nematode

Identifiers

PMID36425211
PMCPMC9667473
OpenAlexW4310336683

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.